Aurobindo Pharma has reported results for third quarter ended December 31, 2014.
The company has registered a fall of 5.71% in its net profit at Rs 394.27 crore for the quarter under review as compared to Rs 418.16 crore for the same quarter in the previous year. However, total income of the company has increased 10.39% at Rs 2109.70 crore for Q3FY15 as compared Rs 1911.08 crore for the corresponding quarter previous year.
On the consolidated basis the company’s net profit declined 7.93% to Rs 384.35 crore for the Q3 FY15 as compared to Rs 417.49 crore in Q3 FY14. However, the total income increased by 49.34% to Rs 3202.08 crore in the quarter under review as compared to Rs 2144.12 crore in the corresponding quarter previous year.
